Bifidobacterium breve cbt br3 strain for promotion of growth and nutraceutical composition for promotion of growth containing the same

Abstract

The present invention relates to a novel Bifidobacterium strain having an excellent growth promoting effect, and a nutraceutical composition for promotion of growth, which contains the strain. The strain of the present invention has a beneficial effect of promoting growth by promoting the digestion of human milk oligosaccharides to enhance immunity together with physical strength.

1 . A  Bifidobacterium breve  CBT BR3  Bifidobacterium  for promotion of growth, internationally deposited with the Korean Collection for Type Culture (KCTC) of the Korea Research Institute of Bioscience and Biotechnology under accession number KCTC 12201BP. 
     
     
         2 . The  Bifidobacterium  of  claim 1 , having genes that degrade human milk oligosaccharides, wherein the genes include genes that encode α-mannosidase, β-mannosidase, endo-β-N-acetylglucosaminidase, sialidase, and α-fucosidase. 
     
     
         3 . The  Bifidobacterium  of  claim 1 , comprising genes that biosynthesize nicotinic acid (B3) and folate (B9). 
     
     
         4 . A nutraceutical composition, comprising a  Bifidobacterium breve  CBT BR3 strain (KCTC 12201BP) according to  claim 1 . 
     
     
         5 . The nutraceutical composition of  claim 4 , comprising live or dried bacteria of the  Bifidobacterium breve  CBT BR3 strain (accession number: KCTC 12201BP) in an amount of 10 8  to 10 12  cfu/g. 
     
     
         6 . The nutraceutical composition of  claim 4 , further comprising one or more other prebiotics selected from the group consisting of  Bifidobacterium longum  subsp.  infantis  CBT BT1 (KCTC 11859BP),  Bifidobacterium bifidum  CBT BF3 (KCTC 12199BP), and  Bifidobacterium longum  CBT BG7 (KCTC 12200BP).